Review Article: Prognostic Value of CK5/6 Expression in Urinary Bladder Carcinoma

Role of HER2 and Claudins in Subtypes of Urothelial Carcinoma Identified Bygata3 and Cytokeratin5\6 Immunohistochemical Study

Telomerase Reverse Transcriptase and miR-34a in diagnosis of non-muscle invasive bladder cancer

Cytokeratin 5/6 Phenotypic Expression in Urothelial Bladder Carcinoma: Relation to Clinicopathological Parameters, FAP and CD147 Immunohistochemical Expression

Keratin 17 Immunohisto chemical Expression and Prognostic Value in Bladder Urothelial Carcinoma

Significance of HER2 expression in urinary bladder cancer: single institutional data

Evaluation of Minichromosome Maintenance Deficient-5 Levels in non-Muscle invasive Bladder Cancer Patients

The Role of Urinary Fibronectin and Telomerase in Patients with Superficial Bladder Cancer after Transurethral Resection Treated with BCG

Evaluation of Serum Bladder Cancer Specific Nuclear Matrix Proteins - 1 levels in Non-Muscle Invasive Bladder Cancer Patients.

ROLE OF NEOADJUVANT CHEMOTHERAPY IN THE CONSERVATIVE MANAGEMENT OF NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) T1